Industry Presentations



  • NON

    Treatment Considerations for High-risk Neuroblastoma

    Speakers:Araz Marachelian, MD, Pediatric Hematologist/Oncologist
    Erin Armideo, NP, Nurse Practitioner

    Duration: 30 minutes

    Presented on: January 27, 2017

    *This session is not eligible for AMA PRA Category 1 CreditsTM


  • Araz Marachelian, MD

    Araz Marachelian, MD

    Araz Marachelian, MD

    Pediatric Hematologist/Oncologist

    Araz Marichelian is a board certified pediatric hematologist oncologist at Children's Hospital Los Angeles. Her research focus is early phase trials in neuroblastoma with an emphasis on immunotherapy.

    She received her bachelor's degree in molecular cell biology and biochemistry from University of California Berkeley and her medical degree from University of California Irvine. She completed her residency and pediatric oncology fellowship at Children's Hospital Los Angeles, and a masters in clinical investigation from the University of Southern California.
  • Erin Armideo, NP

    Erin Armideo, NP

    Erin Armideo, NP

    Nurse Practitioner

    Erin Armideo is a nurse practitioner at Children's Hospital of Philadelphia. She received her bachelors of nursing from the Pennsylvania State University in 2005 and began her career as a pediatric oncology nurse. In 2009 she received a master’s degree in nursing from the University of Pennsylvania pediatric acute care nurse practitioner program. This presentation is sponsored by and made on behalf of United Therapeutics UT.